This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Overgaard, K. Articles by Diemer, N. H. Search for Related Content PubMed PubMed Citation Articles by Overgaard, K. Articles by Diemer, N. H.

Stroke, Vol 23, 1167-1173, Copyright © 1992 by American Heart Association

ARTICLES

Reduction of infarct volume and mortality by thrombolysis in a rat embolic stroke model

K Overgaard, T Sereghy, G Boysen, H Pedersen and NH Diemer
Department of Neurology, University Hospital of Copenhagen, Denmark.

BACKGROUND AND PURPOSE: Thrombolytic therapy with recombinant tissue plasminogen activator was tested in a rat embolic stroke model. METHODS: The rat carotid territory was embolized with arterial-like microthrombi formed under pressure. Hemispheric cerebral blood flow before and after embolization was measured by the intraarterial Xenon- 133 injection method. Fifteen minutes after embolization, 24 rats were treated with 3 mg/kg or 10 mg/kg tissue plasminogen activator, and 27 were treated with saline. Carotid angiography displayed the rate of occlusion of the cerebral arterial supply before and after treatment. Brains were fixed and evaluated neuropathologically and infarct volume was measured. RESULTS: Cerebral blood flow was reduced 70-86% after embolization. The comparison of pretreatment and posttreatment angiography showed significant (p = 0.0005) reperfusion in the treated rats. Thrombolytic therapy significantly reduced the infarct volume from 55.1% to 24.4% of embolized hemisphere volume (p = 0.007) and increased the survival rate from 0.48 to 0.96 (p = 0.0004). Fifty-three percent of the embolized rats recanalized completely after thrombolytic treatment and developed almost no infarction (median volume 2.8%), and all survived. No hemorrhagic complications were observed. CONCLUSIONS: Early thrombolytic therapy induced recanalization and reduced mortality and infarct volume after embolic stroke in this model.

This article has been cited by other articles:

				Z. G. Zhang, L. Zhang, G. Ding, Q. Jiang, R. L. Zhang, X. Zhang, W.-B. Gan, and M. Chopp A Model of Mini-Embolic Stroke Offers Measurements of the Neurovascular Unit Response in the Living Mouse Stroke, December 1, 2005; 36(12): 2701 - 2704. [Abstract] [Full Text] [PDF]

				R. Noor, C. X. Wang, and A. Shuaib Hyperthermia Masks the Neuroprotective Effects of Tissue Plaminogen Activator Stroke, March 1, 2005; 36(3): 665 - 669. [Abstract] [Full Text] [PDF]

				L. Belayev, L. Khoutorova, T. A. Deisher, A. Belayev, R. Busto, Y. Zhang, W. Zhao, and M. D. Ginsberg Neuroprotective Effect of SolCD39, a Novel Platelet Aggregation Inhibitor, on Transient Middle Cerebral Artery Occlusion in Rats Stroke, March 1, 2003; 34(3): 758 - 763. [Abstract] [Full Text] [PDF]

				Z. Zhang, L. Zhang, M. Yepes, Q. Jiang, Q. Li, P. Arniego, T. A. Coleman, D. A. Lawrence, and M. Chopp Adjuvant Treatment With Neuroserpin Increases the Therapeutic Window for Tissue-Type Plasminogen Activator Administration in a Rat Model of Embolic Stroke Circulation, August 6, 2002; 106(6): 740 - 745. [Abstract] [Full Text] [PDF]

				C. A. Molina, J. Montaner, S. Abilleira, J. F. Arenillas, M. Ribo, R. Huertas, F. Romero, and J. Alvarez-Sabin Time Course of Tissue Plasminogen Activator-Induced Recanalization in Acute Cardioembolic Stroke: A Case-Control Study Stroke, December 1, 2001; 32(12): 2821 - 2827. [Abstract] [Full Text] [PDF]

				M. Andersen, K. Overgaard, P. Meden, G. Boysen, and S. C. Choi Effects of Citicoline Combined With Thrombolytic Therapy in a Rat Embolic Stroke Model • Editorial Comment Stroke, July 1, 1999; 30(7): 1464 - 1471. [Abstract] [Full Text] [PDF]

				R. L. Zhang, Z. G. Zhang, M. Chopp, and J. A. Zivin Thrombolysis With Tissue Plasminogen Activator Alters Adhesion Molecule Expression in the Ischemic Rat Brain • Editorial Comment Stroke, March 1, 1999; 30(3): 624 - 629. [Abstract] [Full Text] [PDF]

				S. Tani, T. Shimizu, H. Kasuya, H. Iwasaki, and K. Takashima Induction of Cerebral Thrombosis With Phenytoin in Rats Stroke, November 1, 1995; 26(11): 2081 - 2086. [Abstract] [Full Text]

				R. Kothari, W. Barsan, T. Brott, J. Broderick, and S. Ashbrock Frequency and Accuracy of Prehospital Diagnosis of Acute Stroke Stroke, June 1, 1995; 26(6): 937 - 941. [Abstract] [Full Text]